In the current global market landscape, characterized by cautious Federal Reserve commentary and political uncertainties, investors are navigating through a period of volatility. Despite these challenges, opportunities may arise in stocks that appear to be trading below their estimated value. Identifying such undervalued stocks requires a careful analysis of fundamentals and market sentiment, especially during times when broader indices experience fluctuations. Top 10 Undervalued Stocks Based On Cash Flows Name Current Price Fair Value (Est) Discount (Est) HangzhouS MedTech (SHSE:688581) CN¥62.17 CN¥124.03 49.9% Shenzhen Lifotronic Technology (SHSE:688389) CN¥15.43 CN¥30.85 50% Sudarshan Chemical Industries (BSE:506655) ₹1133.35 ₹2252.97 49.7% Lindab International (OM:LIAB) SEK226.40 SEK450.98 49.8% Absolent Air Care Group (OM:ABSO) SEK255.00 SEK509.76 50% NCSOFT (KOSE:A036570) ₩205500.00 ₩409953.04 49.9% STIF Société anonyme (ENXTPA:ALSTI) €24.60 €49.15 49.9% Informa (LSE:INF) £7.992 £15.92 49.8% Surgical Science Sweden (OM:SUS) SEK159.10 SEK317.10 49.8% RENK Group (DB:R3NK) €18.342 €36.46 49.7% Click here to see the full list of 871 stocks from our Undervalued Stocks Based On Cash Flows screener. Underneath we present a selection of stocks filtered out by our screen. Bonesupport Holding Overview: Bonesupport Holding AB is an orthobiologics company that develops and commercializes injectable bio-ceramic bone graft substitutes globally, with a market cap of SEK25.47 billion. Operations: The company generates revenue from its Pharmaceuticals segment, amounting to SEK814.46 million. Estimated Discount To Fair Value: 20.9% Bonesupport Holding is trading at SEK 387, significantly below its estimated fair value of SEK 489.52, suggesting it may be undervalued based on cash flows. Despite a decline in profit margins from last year, the company shows promising growth prospects with expected annual earnings and revenue growth rates of 72.2% and 33.5%, respectively, outpacing the Swedish market averages. Recent changes in the Nomination Committee reflect strategic ownership shifts that could influence future governance dynamics. Our earnings growth report unveils the potential for significant increases in Bonesupport Holding's future results. Dive into the specifics of Bonesupport Holding here with our thorough financial health report.OM:BONEX Discounted Cash Flow as at Dec 2024 Shenzhou International Group Holdings Overview: Shenzhou International Group Holdings Limited is an investment holding company involved in the manufacture, printing, and sale of knitwear products across Mainland China, the European Union, the United States, Japan, and other international markets with a market cap of approximately HK$90.49 billion. Story Continues Operations: The company generates revenue of CN¥26.38 billion from its operations in the manufacture and sale of knitwear products across various international markets. Estimated Discount To Fair Value: 33.9% Shenzhou International Group Holdings is trading at HK$60.6, significantly below its estimated fair value of HK$91.66, highlighting potential undervaluation based on cash flows. The company’s earnings are expected to grow 12.9% annually, outpacing the Hong Kong market's 11.5%. Despite an unstable dividend track record, revenue growth forecasts of 10.8% per year exceed the market average of 7.8%. Analysts anticipate a stock price rise by 49.5%, indicating positive sentiment. Our comprehensive growth report raises the possibility that Shenzhou International Group Holdings is poised for substantial financial growth. Click here to discover the nuances of Shenzhou International Group Holdings with our detailed financial health report.SEHK:2313 Discounted Cash Flow as at Dec 2024 Ivanhoe Mines Overview: Ivanhoe Mines Ltd. is involved in the mining, development, and exploration of minerals and precious metals primarily in Africa, with a market cap of CA$23.73 billion. Operations: Ivanhoe Mines Ltd. generates revenue through its mining, development, and exploration activities focused on minerals and precious metals in Africa. Estimated Discount To Fair Value: 19.1% Ivanhoe Mines is trading at CA$17.77, below its estimated fair value of CA$21.96, suggesting potential undervaluation based on cash flows. The Kamoa-Kakula Copper Complex's record production enhances future cash flow prospects, with earnings forecasted to grow 42.4% annually, surpassing the Canadian market average of 15.5%. Despite past shareholder dilution and low revenue figures, analysts expect a 42.1% stock price increase due to robust growth projections and operational achievements in the DRC. Our expertly prepared growth report on Ivanhoe Mines implies its future financial outlook may be stronger than recent results. Navigate through the intricacies of Ivanhoe Mines with our comprehensive financial health report here.TSX:IVN Discounted Cash Flow as at Dec 2024 Key Takeaways Navigate through the entire inventory of 871 Undervalued Stocks Based On Cash Flows here. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets. Interested In Other Possibilities? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include OM:BONEX SEHK:2313 and TSX:IVN. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
3 Stocks Including Bonesupport Holding That May Be Trading Below Estimated Value
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...